Psychogenic nonepileptic seizures in children - Psychological presentation, treatment, and short-term outcomes

Tyson Sawchuk1, Jeffrey Buchhalter2

  • 1Alberta Children's Hospital, Calgary, AB, Canada; Alberta Children's Hospital Research Institute, Calgary, AB, Canada.

Epilepsy & Behavior : E&B
|September 27, 2015
PubMed

Insights

Appropriate psychological treatment for pediatric psychogenic nonepileptic seizures (PNESs) leads to high remission rates and significantly reduces emergency department visits. This care pathway improves outcomes for children with PNESs.

Area of Science:

  • Pediatric Neurology
  • Child Psychology
  • Neuropsychiatry

Background:

  • Psychogenic nonepileptic seizures (PNESs) are functional neurological disorder events that mimic epileptic seizures.
  • Accurate diagnosis and management of pediatric PNESs are crucial for effective treatment and improved patient outcomes.
  • Understanding the etiologies and features of PNESs in children is essential for developing targeted interventions.

Purpose of the Study:

  • To investigate the causes, characteristics, and treatment outcomes of psychogenic nonepileptic seizures (PNESs) in a pediatric population.
  • To analyze the diagnostic process and psychological profiles of children with PNESs.
  • To evaluate the effectiveness of psychological interventions in managing pediatric PNESs.

Main Methods:

  • Retrospective analysis of 32 children referred for suspected PNESs over six years.
  • Inclusion of 29 patients with confirmed PNESs after excluding non-epileptic events.
  • Review of patient data including demographics, symptoms, comorbidities, psychological assessments, and treatment protocols (cognitive behavioral therapy, psychiatric medication, family therapy).

Main Results:

  • The study population comprised predominantly adolescents (90%), Caucasian (72%), and female (76%) patients.
  • Patients often presented with high levels of psychic tension, depressive affect, and maladaptive personality traits, while underreporting anxiety.
  • Psychological treatment resulted in high remission rates (59% full, 21% partial) and a sevenfold reduction in emergency department visits post-treatment.

Conclusions:

  • Appropriate care, including accurate diagnosis and psychological treatment, significantly improves remission rates for pediatric PNESs.
  • Referral to psychology services reduces unnecessary medical investigations and healthcare utilization.
  • Integrated care models combining neurology and psychology are effective for managing pediatric PNESs.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.1K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
666
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
966
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.4K